Personalis, Inc. (PSNL)
NASDAQ: PSNL · Real-Time Price · USD
8.31
+0.15 (1.84%)
Mar 10, 2026, 4:00 PM EDT - Market closed
Revenue by Segment
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 |
|---|
Advanced Cancer Genomic Tests for Precision Oncology and Personalized Testing | 69.65M | 84.61M | 73.48M | 65.05M | 85.49M | | | | |
Advanced Cancer Genomic Tests for Precision Oncology and Personalized Testing Growth | -17.69% | 15.15% | 12.97% | -23.92% | 8.70% | | | | |
| 69.65M | 84.61M | 73.48M | 65.05M | 85.49M | | | | |
| -17.69% | 15.15% | 12.97% | -23.92% | 8.70% | | | | |
Revenue by Geography
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 |
|---|
| 62.68M | 81.23M | 66.13M | 65.05M | 85.49M | | | | |
| -22.83% | 22.83% | 1.67% | -23.92% | 8.70% | | | | |
| 6.96M | 3.38M | 7.35M | - | - | | | | |
| 105.78% | -53.94% | - | - | - | | | | |
| 69.65M | 84.61M | 73.48M | 65.05M | 85.49M | | | | |
| -17.69% | 15.15% | 12.97% | -23.92% | 8.70% | | | | |
Source: S&P Global Market Intelligence.
